Comparative statistics by cancer site (ICD-10)

ICD-10: Comparative statistics by registry

Table 4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group


Click on country-registry for comparison

FlagCountry-registryRegistration periodNo. of casesMaleFemaleNumber of cases by age groupRelative survival by age group
5-year survival5-year survival
No.AbsRelNo.AbsRel<4545-5455-6465-7475+<4545-5455-6465-7475+
China - Hong Kong SAR 1996-20019256722318.921.5203319.121.81163172022432605152533.825.820.618.513.1
China - Qidong 1992-2000709053385.15.517525.35.72458181213809464945.56.15.25.07.8
China - Shangai 1992-1995695449527.99.120026.47.398480818042106125212.210.09.08.05.1
China - Tianjin 1991-19996525460622.727.0191918.020.857486117542198113826.627.224.725.024.8
Gambia 1993-1997123912.12.2325027261553.70.00.00.00.0
India - Barshi 1993-200047443210181160.00.00.00.00.0
India - Karunagappally 1991-199754492.22.66161391330.00.013.90.00.0
Singapore 1993-1997155012044.65.43463.64.215719136346937010.96.94.33.74.1
Republic of Korea - Busan 1996-2001650748288.49.316799.610.479717112096140050312.610.69.66.08.0
Republic of Korea - Incheon 1997-20012328171714.215.761116.817.836658976241919220.016.617.812.714.3
Republic of Korea - Seoul 1993-19979872755316.918.7231919.420.8130929183159180268425.318.818.818.313.1
Thailand - Chiang Mai 1993-19977054972.42.52085.35.6171138194150521.16.14.41.20.0
Thailand - Lampang 1990-2000145597611.312.147913.914.921127942637416512.411.511.911.823.4
Thailand - Songkhla 1990-19992712252.22.44659546964257.00.03.50.00.0
Uganda - Kampala 1993-1997116632.32.7533.13.66020211326.70.00.00.00.0
Zimbabwe - Harare 1993-19971321322.93.7342529311310.00.00.00.00.0



Graphs:


Other tables available:

- Table 1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site
- Table 2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site
- Table 2b: Number and proportion of cases by vital status and median follow-up (in months) by site
- Table 3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site
- Table 4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group
- Table 5b: Proportion (%) of cases and 5-year absolute survival by extent of disease and site
- Table 6: Comparison of 5-year absolute and relative survival of cases diagnosed
- Table 7b: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 8: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 9: Up-to-date 10- and 15-year relative survival estimates using cohort and period approaches by site and calendar period